Startups channel feed – Endpoints News

Startups channel feed

Intellia to cut workforce by 27%, plans commercialization of first CRISPR therapy in 2027

6 months ago

Versant unveils Light Horse with $62M and a partnership with Novartis

6 months ago

Leyden Labs gets $70M to test if nasal sprays can help protect against viruses

6 months ago

Coave raises €32M Series A despite being two years away from the clinic

6 months ago

Aiolos team reunites with $411M for new biotech with obesity drugs from China

6 months ago

Gene editing startup Scribe Therapeutics lets go of staff as it preps for the clinic

6 months ago

Solid Bio's former CEO launches new rare disease startup with €65M Series A

6 months ago

Roche's Chugai partners with Swiss ADC biotech Araris

6 months ago

ARCH, F-Prime and Mubadala pump $200M into former Denali programs

6 months ago

Exclusive: GV-backed startup Prudentia launches with $7M to help pharma make better deals, faster

6 months ago

Novo expands pact with Flagship's Valo to include obesity, diabetes for $190M near-term

6 months ago

Maze files for first biotech IPO of 2025, following $115M funding boost

6 months ago

Exclusive: Avenzo picks up another ADC, this time with multi-partnered DualityBio

6 months ago

Exclusive: Forbion-backed cardio biotech rebrands to RyCarma with Phase 2 plans

6 months ago

'Microprotein' biotech Velia, backed by TCG and Foresite, to wind down

6 months ago

Exclusive: Joe Jimenez's Aditum Bio rings in new year with $428M third fund

6 months ago

Exclusive: AI biotech Iambic snags CFO who helped steer Recursion-Exscientia deal

6 months ago

Regeneron buys London-based ocular biotech

6 months ago

A look at biotech's year of the megaround

6 months ago

Immunology biotech Inmagene to join Nasdaq through reverse merger with what's left of Ikena

6 months ago

Sofinnova outlines $550M fund after IPOs and M&A deals

6 months ago

Exclusive: Florida cancer biotech raises $100M Series A

6 months ago

David Epstein gets $140M for Ottimo's bifunctional take on hot PD-1xVEGF field

6 months ago

Updated: Flagship gene therapy startup Ring Therapeutics nearly halves workforce as CEO departs

6 months ago

First page Previous page 5 6 789 10 11 Next page Last page